Theranexus (EPA:ALTHX) | WebDisclosure

BRIEF

published on 12/17/2024 at 18:20, 3 days 18 hours ago

Theranexus optimizes its cash flow and extends its financial horizon

Treasury Funding License Agreement Theranexus Batten Disease
BRIEF

published on 12/17/2024 at 18:20, 3 days 18 hours ago

Theranexus optimise sa trésorerie et prolonge son horizon financier

Financement Trésorerie Accord De Licence Theranexus Maladie De Batten
PRESS RELEASE

published on 12/17/2024 at 18:15, 3 days 18 hours ago

THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON
Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners

Cash Position Cash Flow Financial Debt Theranexus Banking Partners
PRESS RELEASE

published on 12/17/2024 at 18:15, 3 days 18 hours ago

THERANEXUS FAIT UN POINT SUR SA POSITION DE TRÉSORERIE ET SON HORIZON DE FINANCEMENT
Theranexus annonce sa trésorerie au 12 décembre 2024 à 1,5 M€, prévoit un renforcement de 4,8 M€ et étend son horizon financier jusqu'au T1 2026. Accord avec Exeltis et réaménagement de sa dette soulignés

Dette Trésorerie Theranexus Exeltis Horizon Financier
BRIEF

published on 12/17/2024 at 18:05, 3 days 19 hours ago

License agreement between Theranexus and Exeltis for TX01

Rare Diseases License Agreement Theranexus Exeltis TX01
BRIEF

published on 12/17/2024 at 18:05, 3 days 19 hours ago

Accord de licence entre Theranexus et Exeltis pour le TX01

Maladies Rares Accord De Licence Theranexus Exeltis TX01
PRESS RELEASE

published on 12/17/2024 at 18:00, 3 days 19 hours ago

THERANEXUS ET EXELTIS (INSUD PHARMA) ANNONCENT UN ACCORD DE LICENCE POUR LA COMMERCIALISATION DU TX01 DE THERANEXUS DANS LE TRAITEMENT DE DEUX MALADIES NEUROLOGIQUES RARES
Exeltis obtient une licence exclusive pour commercialiser la nouvelle formulation TX01 de Theranexus dans le traitement de deux maladies neurologiques rares en Europe. Des paiements d'étapes et de redevances prévus

Maladies Rares Accord De Licence Theranexus Neurologie Exeltis
PRESS RELEASE

published on 12/17/2024 at 18:00, 3 days 19 hours ago

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS
Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions

License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF

published on 11/19/2024 at 18:05, 1 month 1 day ago

Theranexus présente des résultats positifs pour le traitement de la maladie de Batten CLN3

Essai Clinique Theranexus Batten-1 Maladie De Batten Acuité Visuelle
BRIEF

published on 11/19/2024 at 18:05, 1 month 1 day ago

Theranexus presents positive results for the treatment of Batten disease CLN3

Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity

1 2 ... 6

Published on 12/21/2024 at 01:30, 11 hours 35 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 11 hours 35 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 5 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 13 hours 35 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 14 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 12 hours 20 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 17 hours 55 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 9 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 5 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 48 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 48 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 5 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 19 hours 5 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 10 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News